Distal pancreatectomy with celiac axis resection (DP-CAR) for pancreatic cancer: how I do it

Approximately 30% of all pancreatic cancer patients have locally advanced (AJCC stage 3) disease. A sub-group of these patients - where the cancer only involves the celiac axis - may benefit from distal pancreatectomy with celiac axis resection (DP-CAR). Previous studies have shown that DP-CAR offer...

Full description

Saved in:
Bibliographic Details
Main Authors: Klompmaker, Sjors (Author) , Hackert, Thilo (Author)
Format: Article (Journal)
Language:English
Published: 13 August 2018
In: Journal of gastrointestinal surgery
Year: 2018, Volume: 22, Issue: 10, Pages: 1804-1810
ISSN:1873-4626
DOI:10.1007/s11605-018-3894-7
Online Access:Resolving-System, Volltext: https://doi.org/10.1007/s11605-018-3894-7
Verlag: https://link.springer.com/article/10.1007%2Fs11605-018-3894-7
Get full text
Author Notes:Sjors Klompmaker, Ugo Boggi, Thilo Hackert, Roberto Salvia, Matthew Weiss, Hiroki Yamaue, Herbert J. Zeh, Marc G. Besselink
Description
Summary:Approximately 30% of all pancreatic cancer patients have locally advanced (AJCC stage 3) disease. A sub-group of these patients - where the cancer only involves the celiac axis - may benefit from distal pancreatectomy with celiac axis resection (DP-CAR). Previous studies have shown that DP-CAR offers a survival benefit to a selected group of patients with otherwise unresectable pancreatic cancer, when performed by experienced pancreatic cancer treatment teams at high-volume centers. This article proposes a standardized approach to DP-CAR, including routine neoadjuvant (FOLFIRINOX) chemotherapy. This approach to selecting patients and performing DP-CAR has the potential to improve short-term outcomes and overall survival in selected patients, but it should be reserved for high-volume centers.
Item Description:Gesehen am 11.11.2019
Physical Description:Online Resource
ISSN:1873-4626
DOI:10.1007/s11605-018-3894-7